Headache and facial pain responsive to botulinum toxin: An unusual presentation of blepharospasm

Headache

Volumn 38, Issue 5, 1998, Pages 366-368

  Johnstone, Sharon J ^a   Adler, Charles H ^b  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Blepharospasm; Botulinum toxin; Facial pain; Headache

Indexed keywords

ANTIDEPRESSANT AGENT; BOTULINUM TOXIN A; DIPHENHYDRAMINE; DORZOLAMIDE; HYDROCODONE; NIFEDIPINE; PARACETAMOL; PAROXETINE;

AGED; ARTICLE; BLEPHAROSPASM; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDICATION; FACE PAIN; FEMALE; HEADACHE; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031836855     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1998.3805366.x     Document Type: Article

References (19)

1. Jordan DR, Patrinely JR, Anderson RL, Thiese SM. Essential blepharospasm and related dystonias. Surv Ophthalmol. 1989;34:123-132.
2. Lindeboom R, De Haan R, Aramideh M, Speelman JD. The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm. Mov Disord. 1995;10:444-449.
3. Grandas F, Esteban A. Eyelid motor abnormalities in progressive supranuclear palsy. J Neural Transm Suppl. 1994;42:33-41.
4. Fahn S. Blepharospasm: a form of focal dystonia. Adv Neurol. 1988;49:125-133.
5. Aramideh M, Ongerboer de Visser BW, Holstege G, Majoie CB, Speelman JD. Blepharospasm in association with a lower pontine lesion. Neurology. 1996;46:476-478.
6. Jankovic J. Etiology and differential diagnosis of blepharospasm and oromandibular dystonia. Adv Neurol. 1988;49:103-116.
7. Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord. 1994;9:493-507.
8. Pita Salorio D, Quintana Conte R. Ophthalmologic causes of blepharospasm. Adv Neurol. 1988;49:91-102.
9. Nasr AM. Eyelid complications in trachoma: diagnosis and management. Acta Ophthalmol. 1991;69:200-204.
10. Elston JS, Marsden CD, Grandas F, Quinn NP. The significance of ophthalmological symptoms in idiopathic blepharospasm. Eye. 1988,2:435-439.
11. Price J, O'Day J. A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin. J Clin Neuroophthalmol. 1993;13: 67-71.
12. Araszkiewicz H, Soroka D, Wlodarska-Araszkiewicz A, Markiewicz L. Functional blepharospasm with headache syndrome [in Polish]. Wiad Lek. 1983;36:161-163.
13. Powers JM. Decongestant-induced blepharospasm and orofacial dystonia. JAMA. 1982;247:3244-3245.
14. Borodic GE, Cozzolino D. Blepharospasm and its treatment, with emphasis on the use of botulinum toxin. Plast Reconstr Surg. 1989;83:546-554.
15. Fine PG, Digre KB. A controlled trial of regional sympatholysis in the treatment of photo-oculodynia syndrome. J Neuroophthalmol. 1995;15:90-94.
16. Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology. 1990;40:277-280.
17. Pacchetti C, Albani G, Martignoni E, Godi L, Alfonsi E, Nappi G. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin. Mov Disord. 1995;10:333-336.
18. Fletcher NA, Harding AE, Marsden CD. The relationship between trauma and idiopathic torsion dystonia. J Neurol Neurosurg Psychiatry. 1991;54:713-717.
19. Tolosa E, Montserrat L, Bayes A. Blink reflex studies in patients with focal dystonias. Adv Neurol. 1988;50:517-524.